Age at menopause, hormone therapy linked to BCC risk

Age at menopause, hormone therapy linked to BCC risk
Late age at natural menopause and menopausal hormone therapy use are associated with increased risk of basal cell carcinoma, according to a study published online Nov. 2 in the Journal of Clinical Oncology.

(HealthDay)—Late age at natural menopause and menopausal hormone therapy (MHT) use are associated with increased risk of basal cell carcinoma (BCC), according to a study published online Nov. 2 in the Journal of Clinical Oncology.

Elizabeth K. Cahoon, Ph.D., from the National Cancer Institute in Bethesda, Md., and colleagues used data from the U.S. Radiologic Technologists Study to examine the correlations between reproductive factors, exogenous estrogen use, and first primary BCC. They accounted for sun exposure, personal sun sensitivity, and lifestyle factors for geographically dispersed women with a range of ambient ultraviolet radiation exposure.

The researchers found that the risk of BCC was elevated with late age at natural menopause (hazard ratio for ≥55 years versus 50 to 54 years, 1.5) and with any use of MHT (hazard ratio, 1.16). Women reporting natural menopause who used MHT for 10 or more years had the most increased risk compared with those who never used MHT (hazard ratio, 1.97). There was no correlation for BCC risk with age at menarche, parity, age at first birth, infertility, use of diethylstilbestrol by participant's mother, age at hysterectomy, or oral contraceptive use.

"Novel findings of increased BCC risk associated with MHT in women experiencing natural menopause and for late age at natural menopause warrant further investigation," the authors write. "Users of MHT may constitute an additional high-risk group in need of more frequent skin cancer screening."


Explore further

Menopausal hormone therapy increases risk of gastrointestinal bleeding

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Journal of Clinical Oncology

Copyright © 2015 HealthDay. All rights reserved.

Citation: Age at menopause, hormone therapy linked to BCC risk (2015, November 3) retrieved 19 November 2019 from https://medicalxpress.com/news/2015-11-age-menopause-hormone-therapy-linked.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
26 shares

Feedback to editors

User comments